Objectives:

1. Review of complement pathways

2. Explore the evidence behind the role of complements in ANCA-associated vasculitis

3. Review Avacopan phase II trial

Session date: 
Tuesday, February 27, 2018 - 8:30am to 9:30am
Speaker Name: 
Iazsmin Ventura, M.D.
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.